E2F8 and cancer: Importantly, the overexpression of E2F8 has been shown to induce tumorigenesis and progression while its forced downregulation resulted in the inhibition of tumorigenic phenotypes in several human cancers, such as hepatocellular carcinoma (79), cervical cancer (80), lung cancer (81) and colon cancer (79–82).